Literature DB >> 2454914

Phosphorylation of the B1 (CD20) molecule by normal and malignant human B lymphocytes.

T F Tedder1, S F Schlossman.   

Abstract

The B1 molecule (CD20) is a phosphoprotein found only on B lymphocytes. Multiple isoforms of the B1 molecule are expressed with Mr of 33,000, B1(33) and Mr of 34,500-36,000, B1(35). In this study it was found that nonproliferating B cells did not incorporate 32PO4 into B1 although phosphorylated class I histocompatibility molecules were easily detected. In contrast B1 isolated from proliferating or malignant B cells or B cell lines was heavily phosphorylated. Cross-linking B1 on the cell surface by antibody resulted in enhanced phosphorylation of B1 as did exposure to phorbol esters, and the membrane permeable diacylglycerol analog 1,2,-dioctanoylglyceron. B1(33) and B1(35) produced identical peptide maps following limited proteinase digestion. However, B1(35) contained both phosphoserine and phosphothreonine, while B1(33) only contained phosphoserine. In addition alkaline phosphatase was able to remove the phosphate residue(s) that resulted in generation of the B1(35) form of B1 but was unable to remove the phosphorylation of B1(33). These results suggest that phosphorylation of B1 molecules is associated with proliferation and that the different Mr forms of B1 result from the phosphorylation of B1 at different sites. Also, the finding that antibody binding to B1 generated a transmembrane signal may explain why antibody binding to B1 alters B cell function.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2454914

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

Review 1.  B cell-targeted therapy for rheumatoid arthritis: an update on the evidence.

Authors:  R John Looney
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 2.  Surface molecules involved in B lymphocyte function.

Authors:  P Möller; A Eichelmann; G Moldenhauer
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

Review 3.  CD20-targeting in B-cell malignancies: novel prospects for antibodies and combination therapies.

Authors:  Yaghoub Safdari; Vahideh Ahmadzadeh; Safar Farajnia
Journal:  Invest New Drugs       Date:  2016-04-13       Impact factor: 3.850

4.  Synthesis and evaluation of multivalent branched HPMA copolymer-Fab' conjugates targeted to the B-cell antigen CD20.

Authors:  Russell N Johnson; Pavla Kopecková; Jindrich Kopecek
Journal:  Bioconjug Chem       Date:  2009-01       Impact factor: 4.774

5.  Transfection of the CD20 cell surface molecule into ectopic cell types generates a Ca2+ conductance found constitutively in B lymphocytes.

Authors:  J K Bubien; L J Zhou; P D Bell; R A Frizzell; T F Tedder
Journal:  J Cell Biol       Date:  1993-06       Impact factor: 10.539

Review 6.  Rituximab: mechanisms and applications.

Authors:  P W Johnson; M J Glennie
Journal:  Br J Cancer       Date:  2001-11-30       Impact factor: 7.640

7.  Differences in glycoprotein complexes associated with IgM and IgD on normal murine B cells potentially enable transduction of different signals.

Authors:  J Z Chen; A M Stall; L A Herzenberg; L A Herzenberg
Journal:  EMBO J       Date:  1990-07       Impact factor: 11.598

8.  Analysis of innate and acquired resistance to anti-CD20 antibodies in malignant and nonmalignant B cells.

Authors:  George W Small; Howard L McLeod; Kristy L Richards
Journal:  PeerJ       Date:  2013-02-12       Impact factor: 2.984

9.  Biochemical and biophysical characterization of purified native CD20 alone and in complex with rituximab and obinutuzumab.

Authors:  Morgane Agez; Elodie Desuzinges Mandon; Thomas Iwema; Reto Gianotti; Florian Limani; Sylvia Herter; Ekkehard Mössner; Eric A Kusznir; Sylwia Huber; Matthias Lauer; Philippe Ringler; Claudia Ferrara; Christian Klein; Anass Jawhari
Journal:  Sci Rep       Date:  2019-09-23       Impact factor: 4.379

Review 10.  The regulation and function of CD20: an "enigma" of B-cell biology and targeted therapy.

Authors:  Gabriela Pavlasova; Marek Mraz
Journal:  Haematologica       Date:  2020-06       Impact factor: 11.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.